Measuring the Value of Pharmaceuticals in the US Health System.

The article discusses the value of pharmaceuticals in the U.S. health system. The concept of value is salient in the pharmaceutical market for several reasons, including grant of monopoly to drug manufacturers, competition between payers and between pharmaceutical manufacturing firms, and the value of reputation in the market all serve as checks that limit low-value medications.